(Q33400424)
Statements
1 reference
Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study (English)
1 reference
Suzanne Lentzsch
1 reference
Amy O'Sullivan
1 reference
Ryan C Kennedy
1 reference
Mohammad Abbas
1 reference
Lijun Dai
1 reference
Silvana Lalo Pregja
1 reference
Steve Burt
1 reference
Michael Boyiadzis
1 reference
G David Roodman
1 reference
Markus Y Mapara
1 reference
Mounzer Agha
1 reference
John Waas
1 reference
Yongli Shuai
1 reference
Jeffrey A Zonder
1 reference
26 March 2012
1 reference
1 reference
119
1 reference
20
1 reference
4608-4613
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference